Elective Cardiac Surgery Clinical Trial
Official title:
CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
Prospective, multi-center, randomized, feasibility clinical study. Subjects will be randomized in a 1:1 ratio to either standard of care (SOC) alone or standard of care and treatment with the CytoSorb® device.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02838524 -
Acceptable Range of Inspiratory Effort During Mechanical Ventilation
|
||
Completed |
NCT00879931 -
Influence of Corticoids on Renal Function in Cardiac Surgery
|
Phase 2 | |
Recruiting |
NCT05662501 -
Pleiades Safety and Feasibility Study
|
N/A | |
Completed |
NCT02407873 -
Prognostic Impact of Frailty Assessed by Edmondon in Elderly Patient Undergoing Cardiac Surgery
|
N/A | |
Not yet recruiting |
NCT01418521 -
Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT01748266 -
Microcirculation of the Thenar Eminence
|
N/A | |
Terminated |
NCT03384875 -
CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery
|
N/A |